{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:01:39Z","timestamp":1781650899369,"version":"3.54.5"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2021,1,26]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Primary biliary cholangitis (PBC) is a progressive, autoimmune, cholestatic liver disease affecting approximately 15\u2009000 individuals in the UK. Updated guidelines for the management of PBC were published by The European Association for the Study of the Liver (EASL) in 2017. We report on the first national, pilot audit that assesses the quality of care and adherence to guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Data were collected from 11 National Health Service hospitals in England, Wales and Scotland between 2017 and 2020. Data on patient demographics, ursodeoxycholic acid (UDCA) dosing and key guideline recommendations were captured from medical records. Results from each hospital were evaluated for target achievement and underwent \u03c7<jats:sup>2<\/jats:sup> analysis for variation in performance between trusts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>790 patients\u2019 medical records were reviewed. The data demonstrated that the majority of hospitals did not meet all of the recommended EASL standards. Standards with the lowest likelihood of being met were identified as optimal UDCA dosing, assessment of bone density and assessment of clinical symptoms (pruritus and fatigue). Significant variations in meeting these three standards were observed across UK, in addition to assessment of biochemical response to UDCA (all p&lt;0.0001) and assessment of transplant eligibility in high-risk patients (p=0.0297).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings identify a broad-based deficiency in \u2018real-world\u2019 PBC care, suggesting the need for an intervention to improve guideline adherence, ultimately improving patient outcomes. We developed the PBC Review tool and recommend its incorporation into clinical practice. As the first audit of its kind, it will be used to inform a future wide-scale reaudit.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/flgastro-2020-101713","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T13:20:32Z","timestamp":1615296032000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Widespread gaps in the quality of care for primary biliary cholangitis in UK"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-7599","authenticated-orcid":false,"given":"Mathuri","family":"Sivakumar","sequence":"first","affiliation":[{"name":"Medicine, University of Birmingham, Birmingham, UK"},{"name":"Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eathar","family":"Shakweh","sequence":"additional","affiliation":[{"name":"Gastroenterology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Gastroenterology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Safinia","sequence":"additional","affiliation":[{"name":"Gastroenterology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda Claire","family":"Smith","sequence":"additional","affiliation":[{"name":"Hepatology and Gastroenterology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Marshall","sequence":"additional","affiliation":[{"name":"Hepatology, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Turner","sequence":"additional","affiliation":[{"name":"Gastroenterology, York Teaching Hospital NHS Foundation Trust, York, North Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashis","family":"Mukhopadhya","sequence":"additional","affiliation":[{"name":"Gastroenterology, Grampian University Hospitals NHS Trust, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Nadim","family":"Haboubi","sequence":"additional","affiliation":[{"name":"Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Vincent","sequence":"additional","affiliation":[{"name":"Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey Kuan","family":"Tan","sequence":"additional","affiliation":[{"name":"Gastroenterology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Alrubaiy","sequence":"additional","affiliation":[{"name":"Medicine, Imperial College London, London, UK"},{"name":"Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E J","family":"Jones","sequence":"additional","affiliation":[{"name":"Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"2025090708075527000_13.1.32.1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"2025090708075527000_13.1.32.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259"},{"key":"2025090708075527000_13.1.32.3","first-page":"145","article-title":"A practical review of primary biliary cholangitis for the gastroenterologist","volume":"15","author":"Onofrio","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"2025090708075527000_13.1.32.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.065862"},{"key":"2025090708075527000_13.1.32.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26365"},{"key":"2025090708075527000_13.1.32.6","first-page":"49","article-title":"Clinical updates in primary biliary cholangitis: trends, epidemiology, diagnostics, and new therapeutic approaches","volume":"8","author":"Galoosian","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"2025090708075527000_13.1.32.7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"2025090708075527000_13.1.32.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000226"},{"key":"2025090708075527000_13.1.32.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.029"},{"key":"2025090708075527000_13.1.32.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22428"},{"key":"2025090708075527000_13.1.32.11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cgh.2019.09.050","article-title":"Long-Term obeticholic acid therapy improves histological endpoints in patients with primary biliary cholangitis","volume":"18","author":"Bowlus","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090708075527000_13.1.32.12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2468-1253(19)30094-9","article-title":"Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study","volume":"4","author":"Trauner","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090708075527000_13.1.32.13","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36027"},{"key":"2025090708075527000_13.1.32.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.031"},{"key":"2025090708075527000_13.1.32.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.009"},{"key":"2025090708075527000_13.1.32.16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J Hepatol"},{"key":"2025090708075527000_13.1.32.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"2025090708075527000_13.1.32.18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.023937"},{"key":"2025090708075527000_13.1.32.19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2017.10.018","article-title":"Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090708075527000_13.1.32.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017572"},{"key":"2025090708075527000_13.1.32.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2012-001797"},{"key":"2025090708075527000_13.1.32.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21609"},{"key":"2025090708075527000_13.1.32.23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/apt.15554","article-title":"PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis","volume":"50","author":"Alrubaiy","year":"2019","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2020-101713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:08:03Z","timestamp":1757257683000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2020-101713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,7]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/flgastro-2020-101713"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2020-101713","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]}}}